HIF degrading prolylhydroxylase 2 SNPs are known to be associated with erythrocytosis in humans [10] and PHD2 deficiency evokes erythrocytosis by activating the renal erythropoietin pathway in mice [20]. The gene discussed is EPO; the disease is polycythemia.